{"organizations": [], "uuid": "81c28e75e0266f42fecabe9716baf7965d0c1b8c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/19/pr-newswire-gbt-reports-fourth-quarter-2017-results.html", "country": "US", "domain_rank": 767, "title": "GBT Reports Fourth Quarter 2017 Results", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-03-20T02:46:00.000+02:00", "replies_count": 0, "uuid": "81c28e75e0266f42fecabe9716baf7965d0c1b8c"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/19/pr-newswire-gbt-reports-fourth-quarter-2017-results.html", "ord_in_thread": 0, "title": "GBT Reports Fourth Quarter 2017 Results", "locations": [], "entities": {"persons": [], "locations": [{"name": "uruguay", "sentiment": "none"}, {"name": "montevideo", "sentiment": "none"}, {"name": "latin america", "sentiment": "none"}], "organizations": [{"name": "gbt", "sentiment": "negative"}, {"name": "biotoscana investments s.a.", "sentiment": "negative"}, {"name": "ebitda", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "MONTEVIDEO, Uruguay, March 19, 2018 /PRNewswire/ -- Biotoscana Investments S.A. (B3: GBIO33), a biopharmaceutical group that operates in Latin America, announced today its results for the 4Q17 and full year of 2017.\nHIGHLIGHTS\nGross revenues for 4Q17 grew 14% in constant currency, totaling BRL 271.6M.\nNet revenues for 4Q17 increased by 17.8% in constant currency, totaling BRL 244.4M.\nGross profit up 14.4% in 4Q17, in constant currency, totaling BRL 140.3M. Gross margin of 57.4%.\nAdjusted EBITDA grew 5.5% in constant currency vs. 4Q16, amounting to BRL 73.2M in 4Q17. 19.2% growth excluding from the base an insurance recovery decoupled from its underlying loss (in 2Q17)\nAdjusted net income up 6.9% in nominal terms from 4Q16, reaching BRL 36.9M in 4Q17.\nNet revenues for full year 2017 at 817.5M, with 14% organic growth (excluding exchange rate effects, short-term businesses, divestitures and acquisitions).\nAdjusted EBITDA reached BRL 199.4M in 2017, up 23.9% in constant currency.\nGross margin for full year 2017 improved 3.8 pp when compared to 2016, reaching 53.8%. Adjusted EBITDA margin improved 2.5 pp, reaching 24.4%, in the same period.\nContacts:\nMelissa Angelini\nir@grupobiotoscana.com\n+55 11 5090-5927\nView original content: http://www.prnewswire.com/news-releases/gbt-reports-fourth-quarter-2017-results-300616306.html\nSOURCE Grupo Biotoscana", "external_links": ["http://www.prnewswire.com/news-releases/gbt-reports-fourth-quarter-2017-results-300616306.html"], "published": "2018-03-20T02:46:00.000+02:00", "crawled": "2018-03-20T05:06:39.000+02:00", "highlightTitle": ""}